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Introduction 
Leprosy is the oldest disease known to man. The earliest written records describing true leprosy came from 
India around the period 600 BC1. Leprosy is caused by Mycobacterium leprae; the Norwegian, Dr Amauer 
Hansen, isolated the bacterium in 1873. Leprosy is also called Hansen’s disease after him. Although it is the 
first human pathogenic bacterium to be defined, M. leprae is the only bacterium causing disease in man that has 
not been cultured in the laboratory2.  
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Leprosy situation 
Leprosy is found 
throughout the Sudan with 
areas of concentration in 
the South, West and East. 
Sudan has achieved the 
elimination level of leprosy, 
defined as a prevalence of 
less than 1/10,000 
population. At the end of 
2008, the registered 
prevalence was 1,892 cases. 
The number of newly 
detected cases was 1,901, 
including data from 
Southern Sudan3.  
Stigma of leprosy 
The fear of leprosy leads to the stigma and discrimination and is due 
to lack of understanding and knowledge about leprosy - which 
increases misconceptions about the disease’s transmission and 
treatment. The fact that most of those with untreated leprosy end up 
with severe deformities and disfigurements has contributed to the 
stigma4 – see Figures 1 and 2.  
 
Definition of stigma 
The commonly used definition of stigma is “the attribute that is deeply 
discrediting” and “that reduces the bearer from a whole and usual 
person to a tainted, discounted one”6. 
 
Another definition states that stigma is “a social process that exists 
when elements of labelling, stereotyping, separation, status loss and 
discrimination occur in a power situation that allows them” 7.  
Stigma can be classified into three types:  
 Enacted - the commonest type in which there are actual 
experiences of discrimination. 
 Perceived - stigma viewed from the perspective of the patient.  It 
is “the devaluation, shame, secrecy and withdrawal triggered by 
applying negative stereotypes to oneself”. 
 Self stigma - the fear of being discriminated against5. 
 
Some studies have concluded 
that stigma affects many aspects 
of the lives of people affected by 
leprosy including “mobility, 
interpersonal relationships, 
marriage, employment, leisure 
activities, and attendance at 
social and religious functions” 5. 
Stigma process 
Understanding how stigma 
develops is crucial for planning 
strategies to reduce it Stigma 
associated with leprosy does not 
start immediately after the 
disease starts, but develops over 
time in 2 stages: 
 Stage 1 - the cognitive 
dimension. This describes 
how much influence the 
disease has on the person’s 
life. The patients pass 
through the concealability 
course, disruptive, aesthetic, 
origin and peril dimensions8.  
 Stage 2 - the affective stage 
in which the social 
devaluation of the individual 
occurs. 
Heijnders describes a similar 
process of stigmatisation. In her 
studies in Nepal, she noted that 
people with leprosy go through 
two stages in coping with their 
condition: the concealment 
phase and the exposure phase. 
In moving from one phase to 
the other, there are triggers to 
exposure and discrimination 
such as the visible signs of the 
disease.  However, she found 
that in the process, stigma 
Figure 1. Lepromatous leprosy patient presenting 
at leprosy clinic. Photo: Edward Luka 
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enforces the inequalities that are found in the community with regards 
to gender, age and social class9.  
The impact of stigma 
Having a stigmatising disease like leprosy severely affects aspects of 
life such as social status, employment opportunities or jobs, marriage 
and family life7. These can be summarised as effects on: 
 the individual 
 the community 
 public health programmes and interventions10, 11.  
Effects on the individual 
As noted by Weis and Ramakrishna “the impact of the meaning of the 
disease may be a greater source of suffering than symptoms of the 
disease” 12. Individuals with leprosy have emotional stress and anxiety, 
which may lead to psychological and psychiatric morbidity13, 14, as well 
as a decreased quality of life on the WHO Quality of Life Assessment 
BREFb 14. They become isolated and lack motivation to continue 
treatment (if already started). There is a risk that the disease will 
progress with resultant disability and complications. Individuals may 
have decreased status in the community because of their conditions7. 
In the case of leprosy they may become destitute and resort to begging 
as the only way of survival4, 15.  
Studies have shown that these effects are greater in female than male 
patients16. A review of leprosy patients in South East Nigeria from 
1988 to 1997 found that the effects were greater in women than men. 
The women also tend to present late, have complications and 
disabilities17, 18. 
Effects on community interaction 
The social participation of persons affected by leprosy is much more 
distressing to them than their individual effects. It impairs their quality 
of life in various ways10, 12, 18, 19, 20. Persons with stigmatising conditions 
experience problems in their marriages or difficulties in getting 
married and in their employment or getting employed. Their 
community interaction is affected, such as social relationships and 
friendships. Their families may experience reduced educational 
opportunities, leading to further inequities between those affected and 
those who are not. All of these negative effects result from poor 
community knowledge of the disease, and the misconceptions held 
about them. 
Effects on public health programmes 
The impact of stigma on public health programmes and interventions 
have been well documented and discussed10, 12. People with the 
stigmatising conditions may conceal or deny their condition and delay 
seeking treatment – which may: 
 result in the diseases getting worse and increase the risk of 
complications 
 increase the transmission of the disease in the community  
 make it difficult to trace contacts and those defaulted from 
treatment - important in leprosy and TB21.  
Some patients may not adhere to treatment when diagnosed especially 
for treatment that takes a long time, like TB and leprosy12. Risk of 
drug resistance developing is then very high. In general therefore 
stigma results in an increased burden on the general health services. 
                                                     
b BREF = Best Available Technique Reference document 
 
 
Fighting the stigma of 
leprosy 
Fear and stigma are difficult to 
remove. They can only be dealt 
with through a combination of 
strategies. Heijnders and van der 
Meij10 described 11 levels of 
interventions and strategies that 
can be use to fight stigma. These 
focused on: 
 changing the image of the 
diseases 
 integrating programmes 
 rehabilitating patients and  
 media campaigns. 
These interventions are now 
used in most leprosy control 
programmes.  
 
WHO encourages integrating 
leprosy into the general health 
service. Leprosy patients should 
be treated in the same outpatient 
department as those with any 
other disease, showing the 
patients and their communities 
that leprosy is not a 'different' 
disease. Different countries are 
in different stages of 
implementing these 
interventions that have been 
shown to reduce stigma19.  
 
Education and media campaigns 
help to correct false beliefs and 
raise awareness of new advances. 
They include information about 
leprosy and its treatment, 
context-specific media messages 
addressing misconceptions and 
traditional beliefs about leprosy, 
positive images of leprosy and 
testimonies of people 
successfully cured of leprosy22.  
Physical and socio-economic 
rehabilitation helps to restore 
self-esteem and status in the 
community, and assists patients 
to find employment. Most 
studies have shown that the 
stigma of leprosy is aggravated 
by the physical deformities 
associated with the disease19, 23, 
24. So programmes that prevent 
disabilities developing or identify 
patients most at risk of 
developing them, can reduce the 
effects of stigma20, 25.  
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Psychological or physical changes reported by the patients can predict 
development of participation restriction (i.e. the reduction of their 
involvement in life situations such as social, economic, civic, 
interpersonal, domestic and educational domains of daily living). 
A study in Nepal showed that people affected by leprosy who were in 
the Stigma Elimination 
Programme (STEP) 26 
were less stigmatised and 
participated more in the 
community than those 
who were not. The 
assessment of the stigma 
in this study used the 
Participation Scale 
developed by van 
Brakel11.  STEP 
participants were more 
empowered and become 
change agents in their 
own communities. This kind of intervention has been proven to be 
effective, as demonstrated in Ethiopia27.  
 
Social marketing strategies (the designing and implementing of 
programmes to bring social change by using the concepts of 
commercial marketing) can change community attitudes to leprosy. 
When used correctly, they can be highly effective at reducing stigma 
and improving the lives of patients. Social marketing can be done 
through mass media campaigns, schools and involvement of 
community leaders. These methods have been successfully 
implemented in Sri Lanka28, 29.  
Conclusions 
Leprosy has always been linked with stigma. For many people stigma 
is synonymous with leprosy. This is due to: 
 leprosy often causing severe disfigurement and disability 
 lack of knowledge about the disease.  
 
The key messages that can overcome stigma are:  
 leprosy is curable 
 drug treatment is available free of charge 
 there is no need to discriminate against people affected by 
leprosy.  
If the misconceptions about leprosy are not changed, it will be 
difficult to eliminate leprosy as a public health problem. 
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The need for culturally-relevant research 
Two studies highlight the need local research (like the article above). These looked at the gap between 
research and practice in four areas of the Millennium Development Goals (malaria, contraception, childhood 
diarrhoea and childhood tuberculosis) across 10 low- and middle-countries. Results showed that: 
 % of Healthcare providers who, at least once a month, read journals: 
− From their own country = 18% 
− From high –income countries = 5-8% 
 % who would change clinical practice based on research from: 
− own country = 85% 
− own region = 66% 
− from high-income country = 56% 
See: SciDevNet article http://www.scidev.net/en/news/gulf-between-health-researchers-and-doctors-highlighted.html and 
Bridging the gaps between research, policy and practice in low- and middle-income countries: a survey of health care providers 





Quiz: Do you know? 
 Which five risk factors are responsible for 80% of all risks for stroke? 
 Which is the most important? 
Answers on page 59. 
 
 
